Document is current
Any future updates will be listed below
-
Authors
Collignon, Clément
Hansen, Tucker https://orcid.org/0000-0002-3948-073X
Hercus, Colin https://orcid.org/0000-0001-8997-7130
Ruzinova, Marianna B.
Roth Guepin, Gabrielle
Bonmati, Caroline
Rubio, Marie Thérèse https://orcid.org/0000-0003-3732-5442
Feugier, Pierre
Gaudfrin, Mélanie
Sartelet, Hervé
Divoux, Marion https://orcid.org/0000-0002-5946-311X
Muller, Marc
Heath, Sharon
Uy, Geoffrey L.
Spencer, David H. https://orcid.org/0000-0002-5314-3043
Chen, David Y. https://orcid.org/0000-0002-3681-6576
Pagliuca, Simona
Ferraro, Francesca https://orcid.org/0000-0003-0098-9819
-
Funding
Funding for this research was provided by:
Leukemia Research Foundation
- License Information
-
More Information
Article History
Received: 4 May 2025
Revised: 8 July 2025
Accepted: 30 July 2025
First Online: 13 August 2025
Competing interests
: The authors declare no competing interests.
: All methods were performed in accordance with the relevant guidelines and regulations. Informed consent was obtained from all participants for the use of residual biological specimens collected during clinical sampling for sequencing purposes. Ethics approval was obtained from the following institutional review boards: Nancy University Hospital Ethics Committee (IRB Nancy n° 2024PI205-290) and the Washington University in St. Louis Institutional Review Board (IRB #201011766). This study does not include any identifiable images or other personal details of participants.
